Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Mutares Aktie 43469302 / DE000A2NB650

28.10.2025 08:00:13

EQS-News: Mutares plans to expand its presence in Asia with strategic add-on acquisition of HSR and HST from Hwaseung Corporation for Amaneos China

EQS-News: Mutares SE & Co. KGaA / Key word(s): Investment/Takeover
Mutares plans to expand its presence in Asia with strategic add-on acquisition of HSR and HST from Hwaseung Corporation for Amaneos China

28.10.2025 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Mutares plans to expand its presence in Asia with strategic add-on acquisition of HSR and HST from Hwaseung Corporation for Amaneos China

  • Planned majority takeover of HSR and HST as add-on acquisition for Amaneos China strengthening the Automotive & Mobility segment of Mutares
  • Strategic expansion of the Group’s Asian footprint
  • Revenues of over EUR 100 million
  • Signing of transaction envisaged in Q4 2025

Munich, October 28, 2025 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has entered into final negotiations with Korean listed Hwaseung Corporation to acquire 67% of the shares in Hwaseung Special Rubber (Taicang) Co., Ltd. (“HSR”) and Hwaseung Auto Parts (Taicang) Co., Ltd. (“HST”). This potential acquisition of a majority stake in a leading automotive supplier in China marks a significant milestone in Mutares’ global expansion and targeted growth strategy in Asia. Hwaseung Corporation today disclosed the potential takeover on the Korean stock exchange. Signing of the transaction is envisaged for the fourth quarter of 2025.

The targeted companies are renowned for their indispensable rubber sealing and hose products, serving blue-chip automotive OEMs such as GM, VW, Hyundai, Kia, and Xiaomi. With two state-of-the-art manufacturing sites and a workforce of approximately 600 employees, the companies generated revenues of over EUR 100 million in 2024. HSR and HST make a perfect fit for Amaneos China, unlocking significant value-chain synergies, particularly through the integration with SMA China and SFC China, enabling cost optimization, operational improvements, and a strengthened competitive position in the world’s most dynamic automotive market.

Mutares’ entry into China’s automotive sector reinforces its position as an operational frontrunner in the Automotive & Mobility segment, extending the Group’s track record and opening new opportunities for collaboration with leading Asian and international OEMs. The decision by a prominent Korean stock exchange listed seller to transact with Mutares reflects the Group’s global standing as reliable and value-creating owner with a proven track record in operational excellence, transformation, and sustainable growth.

Johannes Laumann, CIO of Mutares, comments: “Our expansion into Asia marks a major milestone for Mutares in the Automotive & Mobility segment. We are honored by the trust of our Korean partners and excited to bring our operational expertise to the Chinese market. This acquisition is a testament to our commitment to international growth and diversification, and it will generate value for all stakeholders.”

 

Company profile of Mutares SE & Co. KGaA

Mutares SE & Co. KGaA, Munich (http://www.mutares.com), a listed private equity holding company with offices in Munich (HQ), Amsterdam, Bad Wiessee, Chicago, Frankfurt, Helsinki, London, Madrid, Milan, Mumbai, Paris, Shanghai, Stockholm, Vienna and Warsaw, acquires companies in special situations which show significant operational improvement potential and are sold again after undergoing a repositioning and stabilization process.
The shares of Mutares SE & Co. KGaA are traded on the Regulated Market of the Frankfurt Stock Exchange under the symbol "MUX" (ISIN: DE000A2NB650) and are part of the selection index SDAX.

For more information, please contact:

Mutares SE & Co. KGaA
Investor Relations
Phone: +49 89 9292 7760
E-mail: ir@mutares.de
www.mutares.com

Press Contact in Germany
CROSS ALLIANCE communication GmbH
Susan Hoffmeister
Phone: +49 89 125 09 0333
E-mail: sh@crossalliance.de
www.crossalliance.de

Press Contact in France
CLAI
Matthieu Meunier
Phone: +33 06 26 59 49 05
E-mail: matthieu.meunier@clai2.com

Press Contact in UK
14:46 Consulting
Tom Sutton
Phone: +44 7796 474940
E-mail: tsutton@1446.co.uk

 



28.10.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Mutares SE & Co. KGaA
Arnulfstr.19
80335 Munich
Germany
Phone: +49 (0)89-9292 776-0
Fax: +49 (0)89-9292 776-22
E-mail: ir@mutares.de
Internet: www.mutares.de
ISIN: DE000A2NB650
WKN: A2NB65
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2218488

 
End of News EQS News Service

2218488  28.10.2025 CET/CEST

Analysen zu Mutares

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
12.08.25 Mutares Buy Jefferies & Company Inc.
17.06.25 Mutares Buy Warburg Research
30.04.25 Mutares Buy Hauck Aufhäuser Lampe Privatbank AG
08.11.24 Mutares Buy Hauck Aufhäuser Lampe Privatbank AG
17.10.24 Mutares Buy Hauck Aufhäuser Lampe Privatbank AG
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall

Im BX Morning Call spricht die Schweizer Unternehmer-Ikone Etienne Jornod (OM Pharma) mit François Bloch und Olivia Hähnel (BX Swiss) über Führung, Wachstum, Kooperationen, seine Zeit bei der NZZ und darüber, warum Zuhören der wichtigste Leadership-Skill ist.

Die perfekte Folge für alle, die sich für Pharmastrategien, Galenica/Vifor und Unternehmertum interessieren.

🎯 Themen im Interview mit Etienne Jornod (OM Pharma)

– Antrieb und Führungsphilosophie eines Unternehmers
– Erfolgsweg von Galenica – Lehren aus Jahrzehnten Führung
– Frauenquote, Teamkultur und Leadership bei OM Pharma
– Internationale Expansion: China, USA und neue Märkte
– Forschung, Druck und Verantwortung in der Pharmaindustrie
– Inspiration, Balance und persönliche Haltung zum Erfolg
– Zukunftsvisionen: Schweiz, Unternehmertum und Investments

👉🏽 https://bxplus.ch/bx-musterportfolio/

Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’883.91 19.26 B1LSOU
Short 13’136.54 13.87 B02SIU
Short 13’648.79 8.82 BE6SJU
SMI-Kurs: 12’339.73 29.10.2025 14:28:31
Long 11’841.51 19.87 SQFBLU
Long 11’538.54 13.49 BO0SVU
Long 11’008.02 8.64 BMQS4U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

Mutares 26.19 0.48% Mutares